阻塞性睡眠呼吸暂停低通气综合征在临床路径实施过程中的评价
【摘要】
目的：制订并运用关于个性化口腔矫治器治疗OSAHS的临床路径，收集患者在治疗费用、患者满意度、诊疗次数和治疗效果方面的观测指标，来评价个性化口腔矫治器治疗OSAHS疾病实施临床路径与未实施临床路径的效果对比，为个性化口腔矫治器治疗OSAHS进入临床路径的成功提供参考依据，以加强该病种的临床路径管理。
方法：将经PSG诊断患有OSAHS并同意使用口腔矫治器（个性化的下颌前伸的口腔矫治器）治疗的40例轻、中度患者，随机分成两组，一组进入临床路径，另一组不进入临床路径，进入常规的个性化口腔矫治器治疗组。对所获计量资料用均数±标准差进行分析，两样本比较采用成组t检验，治疗前后两样本比较采取配对t检验，以P<0.05为差异有统计学意义。
结果：2组OSAHS患者在戴用个性化口腔矫治器前后PSG检测显示治疗均有很好的临床效果，但两者的临床疗效比较差异无统计学意义（P>0.05）。进入临床路径的一组在治疗费用、时间花费和患者满意度等方面要优于对照组，差异有统计学意义（P＜0.01）。
结论：开展个性化的口腔矫治器能够改善OSAHS患者呼吸睡眠阻塞症状，提高患者生活质量，但是在实施临床路径与未实施临床路径的两者间比较差异不大。个性化口腔矫治器治疗OSAHS实施临床路径的运用确实能降低就诊次数、降低治疗费用和提高患者满意度。
【关键词】阻塞性睡眠呼吸暂停低通气综合征；临床路径；个性化口腔矫治器；评价
The evaluation of obstructive sleep apnea hypopnea syndrome In process of clinical pass way implementation(https://www.daowen.com)
Abstract
Objective：Formulation and use of the clinical pathway of personalized oral correction device in the treatment of OSAHS，collect the patient in the cost of treatment，patients’satisfaction，diagnosis and treatment times and treatment effect of observation index，to evaluate the individualized oral rectification device implementation of clinical pathway in the treatment of OSAHS disease，compared with that without the effect of the implementation of clinical pathway for personalized oral rectification device provides some references for the treatment of OSAHS into the success of clinical pathway，in order to strengthen the disease types of clinical pathway management.
Methods：Will be subject to consent by the PSG diagnosed with OSAHS and use of oral appliance apparatus（personalized jaw forward oral appliance）treatment of 40 cases of mild and moderate OSAHS patients，randomly divided into two groups，a group into the clinical pathway，another group into the routine of personalized oral treatment，treatment group.On the measurement data obtained with mean+/-standard deviation were analyzed，and the two samples compared with group t test，two samples before and after treatment comparison，the paired t test with P<0.05 for the difference was statistically significant.
Results：Two groups in OSAHS patients with personalized oral PSG detection display treatment before and after the rectification device are very good clinical effect，but the clinical curative effect is no statistical difference（P>0.05）.Into a group of clinical pathway in the treatment of costs，time，cost and patient satisfaction is better than that in control group，the difference was statistically significant（P<0.01）.
Conclusion：Our individualized oral rectification device can improve respiratory sleep in patients with OSAHS obstruction symptoms，improve patient quality of life，but not the implementation of clinical pathway in the implementation of clinical pathway and the comparison of difference between the two.Personalized treatments oral treatment OSAHA implement the use of clinical pathway can really reduce the treatment cost，reduce The Times of patients and improve patient satisfaction.
Key words：obstructive sleep apnea hypopnea syndrome；clinical path way；individuation oral appliance；evaluate